Exothera is a specialised Contract Development and Manufacturing Organisation (CDMO) providing end-to-end services for viral vector and RNA therapeutics and vaccines, from pre-clinical to commercial GMP manufacturing. It leverages in-house innovations and extensive expertise to support drug developers in delivering high-quality products efficiently.

Exothera, a part of the Univercells group, offers advanced manufacturing solutions for viral vectors, including AAV, AV, and LVV, and nucleic acids using their Ntensify™ platform. With facilities in Belgium and the US, Exothera is dedicated to accelerating client timelines and reducing costs.

Key Products and Services

• Viral vector services (AAV, AV, LVV, baculovirus, MVA, VLP)
• Nucleic acid services (RNA, mRNA, plasmids)
• Development and scale-up for clinical to commercial stages
• GMP manufacturing

Exothera stands out for its customer satisfaction, advanced technologies, and comprehensive services that ensure the successful development and commercialisation of biopharmaceuticals.